Literature DB >> 337982

Effect of testosterone cypionate on postexercise ST segment depression.

M D Jaffe.   

Abstract

A randomised double blind study was carried out with 50 men who had ST segment depression of 0.1 mV or more after a modified two-step exercise test. Rate and duration of exercise were the same for the last of each subject's several pretreatment tests as for his tests after 4 and 8 weeks of treatment with placebo or testosterone cypionate, 200 mg, intramuscularly weekly. The sum of ST segment depression in leads II, V4, V5, and V6 taken immediately, and 2, 4, and 6 minutes after exercise did not change significantly after 4 or 8 weeks of placebo treatment, but did decrease by 32 per cent (P less than 0.0001) and 51 per cent (P less than 0.0001) after 4 and 8 weeks, respectively, of testosterone cypionate treatment. The mechanism by which testosterone cypionate treatment results in lessened postexercise ST segment depression is not established.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 337982      PMCID: PMC483399          DOI: 10.1136/hrt.39.11.1217

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  12 in total

1.  Comparison of internal mammary artery ligation and sham operation for angina pectoris.

Authors:  E G DIMOND; C F KITTLE; J E CROCKETT
Journal:  Am J Cardiol       Date:  1960-04       Impact factor: 2.778

2.  Seminal vesicle response to androgen with adrenaline, noradrenaline and acetylcholine.

Authors:  J A GRUNT; J T HIGGINS
Journal:  Am J Physiol       Date:  1960-01

Review 3.  Androgens and erythropoiesis.

Authors:  N T Shahidi
Journal:  N Engl J Med       Date:  1973-07-12       Impact factor: 91.245

4.  Testosterone-induced depression of adrenergic activity in the perfused canin hindlimb.

Authors:  S Greenberg; D C Heitz; J P Long
Journal:  Proc Soc Exp Biol Med       Date:  1973-03

5.  Androgens and human blood volume changes. Comparison in normal and various anemic states.

Authors:  E C Besa; D Gorshein; F H Gardner
Journal:  Arch Intern Med       Date:  1974-03

6.  Incidence of cardiovascular disease and death in patients receiving diethylstilbestrol for carcinoma of the prostate.

Authors:  C E Blackard; R P Doe; G T Mellinger; D P Byar
Journal:  Cancer       Date:  1970-08       Impact factor: 6.860

7.  The mechanism by which female hormones enlarge collateral arteries.

Authors:  M D Jaffe; P W Rowe
Journal:  Mich Med       Date:  1972-07

8.  Androgen-induced increase in red-cell 2,3-diphosphoglycerate.

Authors:  J P Parker; G J Beirne; J N Desai; P C Raich; N T Shahidi
Journal:  N Engl J Med       Date:  1972-08-24       Impact factor: 91.245

Review 9.  Exercise stress testing in evaluation of patients with ischemic heart disease.

Authors:  R A Bruce; T R Hornsten
Journal:  Prog Cardiovasc Dis       Date:  1969-03       Impact factor: 8.194

10.  Effect of oestrogens on postexercise electrocardiogram.

Authors:  M D Jaffe
Journal:  Br Heart J       Date:  1976-12
View more
  15 in total

Review 1.  Advancements in pharmacotherapy for angina.

Authors:  Ankur Jain; Islam Y Elgendy; Mohammad Al-Ani; Nayan Agarwal; Carl J Pepine
Journal:  Expert Opin Pharmacother       Date:  2017-03-15       Impact factor: 3.889

Review 2.  The vasodilatory action of testosterone: a potassium-channel opening or a calcium antagonistic action?

Authors:  Richard D Jones; Peter J Pugh; T Hugh Jones; Kevin S Channer
Journal:  Br J Pharmacol       Date:  2003-03       Impact factor: 8.739

Review 3.  Testosterone, myocardial function, and mortality.

Authors:  Vittorio Emanuele Bianchi
Journal:  Heart Fail Rev       Date:  2018-09       Impact factor: 4.214

4.  Testosterone and cardiovascular disease in men.

Authors:  Paul D Morris; Kevin S Channer
Journal:  Asian J Androl       Date:  2012-04-23       Impact factor: 3.285

Review 5.  Antagonist molecules in the treatment of angina.

Authors:  Ashish K Gupta; David Winchester; Carl J Pepine
Journal:  Expert Opin Pharmacother       Date:  2013-09-18       Impact factor: 3.889

6.  Testosterone replacement in hypogonadal men with angina improves ischaemic threshold and quality of life.

Authors:  C J Malkin; P J Pugh; P D Morris; K E Kerry; R D Jones; T H Jones; K S Channer
Journal:  Heart       Date:  2004-08       Impact factor: 5.994

7.  Treatment of Men for "Low Testosterone": A Systematic Review.

Authors:  Samantha Huo; Anthony R Scialli; Sean McGarvey; Elizabeth Hill; Buğra Tügertimur; Alycia Hogenmiller; Alessandra I Hirsch; Adriane Fugh-Berman
Journal:  PLoS One       Date:  2016-09-21       Impact factor: 3.240

Review 8.  Testosterone replacement therapy and cardiovascular risk.

Authors:  Thiago Gagliano-Jucá; Shehzad Basaria
Journal:  Nat Rev Cardiol       Date:  2019-09       Impact factor: 32.419

9.  Intrinsic responses of rat coronary arteries in vitro: influence of testosterone, calcium, and effective transmural pressure.

Authors:  Peter J Pugh; Richard D Jones; T Hugh Jones; Kevin S Channer
Journal:  Endocrine       Date:  2002-11       Impact factor: 3.925

10.  Connecting the Lines between Hypogonadism and Atherosclerosis.

Authors:  Akl C Fahed; Joanna M Gholmieh; Sami T Azar
Journal:  Int J Endocrinol       Date:  2012-02-16       Impact factor: 3.257

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.